Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

Fewer than 10% of dermatology patients who were seen virtually during the COVID pandemic said they would not use teledermatology again—and only 7% said they’d not recommend telehealth to a friend.

Google searches for “telehealth” have fallen far since peaking in March 2020. However, the term is plateauing at a rate that’s 320% higher than in pre-pandemic times.

The idea is to head off serious gathering threats without getting thrown off the scent by strains unlikely to proliferate.

AI melanoma detectors that equaled or bettered dermatologists in clinical trials have stumbled on the way to the real world of patient care. 

The tools could be used by primary care providers to head off adverse respiratory events and suboptimal healthcare utilization. 

An AI application that interprets MRI scans of the brain for signs or confirmation of injury has received 510(k) clearance from the FDA.

The agency has posted an interactive map showing the locations of drug distributors that have recently received shipments of two monoclonal antibody medications good for treating COVID-19.